Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications

K Koltai, G Kesmarky, G Feher, A Tibold… - International journal of …, 2017 - mdpi.com
Platelets play a fundamental role in normal hemostasis, while their inherited or acquired
dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several …

Complications of endovascular treatment for intracranial aneurysms: management and prevention

YK Ihn, SH Shin, SK Baik… - Interventional …, 2018 - journals.sagepub.com
Endovascular coiling for intracranial aneurysms has become an accepted treatment with
good clinical results and provides adequate protection against rebleeding and rupture of …

Ticagrelor versus clopidogrel in the dual antiplatelet regimen for intracranial stenting or flow-diverter treatment for unruptured cerebral aneurysms: a single-center …

KY Park, T Ozaki, A Kostynskyy… - American Journal …, 2021 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Ticagrelor is a novel P2Y12 antagonist, and little is known
about its efficacy and safety in the endovascular treatment of aneurysms. This study …

Effect of adjusted antiplatelet therapy on preventing ischemic events after stenting for intracranial aneurysms

W Li, W Zhu, A Wang, G Zhang, Y Zhang, K Wang… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: This study tests whether patients with unruptured intracranial
aneurysm who underwent stent placement benefitted from platelet function monitoring …

Management of antiplatelet therapy in patients undergoing neuroendovascular procedures

KS Kim, JF Fraser, S Grupke, AM Cook - Journal of Neurosurgery, 2017 - thejns.org
Neuroendovascular techniques for treating cerebral aneurysms and other cerebrovascular
pathology are increasingly becoming the standard of care. Intraluminal stents, aneurysm …

Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update

CM Schirmer, KR Bulsara, F Al-Mufti… - Journal of …, 2023 - jnis.bmj.com
Background Antiplatelet and antithrombotic medication management before, during, and
after neurointerventional procedures has significant practice variation. This document …

Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization …

G Hwang, W Huh, JS Lee, JB Villavicencio… - JAMA …, 2015 - jamanetwork.com
Importance Thromboembolism is the most common complication in coiling for an unruptured
aneurysm and is frequent in patients with high on-treatment platelet reactivity (HTPR) who …

Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with …

AP Narata, A Amelot, R Bibi, D Herbreteau… - …, 2019 - journals.lww.com
BACKGROUND Dual antiplatelet therapy (DAPT) associating aspirin+ clopidogrel is
commonly utilized in neurovascular interventions despite unpredictable clopidogrel efficacy …

Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter/disrupter: a matched-cohort study …

S Soize, C Foussier, PF Manceau, CF Litré… - Journal of …, 2019 - Elsevier
Purpose Standard dual antiplatelet therapy (DAPT) for complex aneurysms treated with flow
diversion and flow disruption is acetylsalicylic acid (ASA) plus clopidogrel. However …

Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic …

JED Almandoz, Y Kadkhodayan, BM Crandall… - Journal of …, 2014 - jnis.bmj.com
Background and purpose Variability in response to clopidogrel therapy is increasingly being
recognized as an important factor in thromboembolic and hemorrhagic complications …